Item #100106, 500ML bottles benchmark fetal bovine serum in (lot A11D00C)
Ended Awarded
- Contract number
- HHSN26100017
- Awardee
-
Gemini Bioproducts LLC UEI TPLGWKT6AM88
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,419
Award facts
- Contract value 100% obligated
- $6,419.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621511 Medical Laboratories
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Fixed Price with Economic Price Adjustment
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN26100017?
HHSN26100017 was awarded to Gemini Bioproducts LLC by National Cancer Institute (National Institutes of Health) on May 17, 2012.
How much is contract HHSN26100017 worth?
The government has obligated $6,419 on HHSN26100017.
Is contract HHSN26100017 an order under another contract?
Yes. HHSN26100017 is a BPA call under HHSN263199700048255B, a blanket purchase agreement.
Was contract HHSN26100017 competed?
The extent of competition for HHSN26100017 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award